MiRagen reports loss, effects reverse stock split Tim November 12, 2020 BOULDER — miRagen Therapeutics Inc. (Nasdaq: MGEN), a Boulder-based biotechnology company developing new treatments for patients with diseases that are […] Source: BizWest
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development. View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving… Tim December 2, 2022
Biotechnology boom The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different… Tim December 25, 2022
Brickell Biotech launches brand reset amid positioning pivot BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as… Tim September 7, 2022
Lightning eMotors seeks reverse stock split to remain on NYSE LOVELAND — In an effort to boost its stock price above $1 and maintain its listing on the New York… Tim December 28, 2022
Flatiron Park’s next phase BOULDER — So, it’s early 2022, COVID-19 is wreaking havoc on the market for office space, and you’ve just made… Tim February 12, 2023